title: New data supporting modified RECIST (mRECIST) for Hepatocellular Carcinoma.
abstract: The modified Response Evaluation Criteria in Solid Tumors (mRECIST) guideline has introduced specific amendments to standard RECIST to address the unique complexities involved in the evaluation of tumor response in hepatocellular carcinoma. A growing amount of data suggests that mRECIST, designed for response assessment in clinical trials, may translate into a tool for clinical practice.
authors: Division of Diagnostic Imaging and Intervention, Pisa University School of Medicine, Pisa, Italy. riccardo.lencioni@med.unipi.it
authors: Riccardo
authors: R
authors: Lencioni
mesh_terms: D006528:Carcinoma, Hepatocellular / Q000453:epidemiology*; D005260:Female; D017408:Guidelines as Topic; D006801:Humans; D008113:Liver Neoplasms / Q000453:epidemiology*; D008297:Male; D016019:Survival Analysis